Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10371	Companies
216166	Keywords
145880	Articles
114460	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 03/11/2026 at 08:00, 1 month 28 days ago

BIOPHYTIS ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
Biophytis completes over €2.0 million capital increase and repays all variable price convertible debt, attracting investments from U.S. healthcare institutions and strengthening financial structure for clinical development in sarcopenia and obesity

Biophytis Healthcare Institutions Capital Increase Clinical Development Convertible Debt
REGULATED PRESS RELEASE

published on 03/11/2026 at 08:00, 1 month 28 days ago

BIOPHYTIS ANNONCE LA REALISATION D’UNE LEVEE DE FONDS DE PLUS DE 2 MILLIONS D’EUROS ET LE REMBOURSEMENT DE L’INTEGRALITE DE SA DETTE CONVERTIBLE A PRIX VARIABLE
Biophytis annonce l'augmentation de capital de plus de 2 millions d'euros, le remboursement de dettes et l'utilisation des fonds levés pour la recherche médicale et les partenariats

Biophytis Levée De Fonds Sarcopénie Obésité Dette Convertible
BRIEF

published on 02/27/2026 at 23:05, 2 months 9 days ago

Biophytis Expands Bond Facility with Hexagon Capital to €2 Million

Biophytis Clinical Development Financial Strategy Hexagon Capital Bond Facility
BRIEF

published on 02/27/2026 at 23:05, 2 months 9 days ago

Biophytis augmente sa ligne obligataire avec Hexagon Capital Fund

Biophytis Financement Obligataire Hexagon Capital Fund 12% Intérêt Obésité Et Sarcopénie
REGULATED PRESS RELEASE

published on 02/27/2026 at 23:00, 2 months 9 days ago

Biophytis porte à 2 m€ le plafond de sa ligne obligataire avec Hexagon Capital Fund
Biophytis porte à 2 m€ le plafond de sa ligne obligataire avec Hexagon Capital Fund pour renforcer sa structure financière et étendre son horizon de trésorerie. Stanislas Veillet et Jean-Philippe Cridlig se félicitent de ce partenariat

Biophytis Financement Développement Clinique Obligataire Hexagon Capital Fund
REGULATED PRESS RELEASE

published on 02/27/2026 at 23:00, 2 months 9 days ago

Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Biophytis increases its bond facility ceiling to €2 million with Hexagon Capital Fund, extending subscription period and strengthening financial structure

Biophytis Financial Structure Subscription Period Hexagon Capital Fund Bond Facility
PRESS RELEASE

published on 02/27/2026 at 22:59, 2 months 9 days ago

Biophytis porte à 2 m€ le plafond de sa ligne obligataire avec Hexagon Capital Fund
Biophytis augmente sa ligne obligataire à 2 m€ avec Hexagon Capital Fund pour renforcer sa structure financière et étendre son horizon de trésorerie

Biophytis Financement Obligations Développement Clinique Hexagon Capital Fund
PRESS RELEASE

published on 02/27/2026 at 22:59, 2 months 9 days ago

Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Biophytis increases bond facility to €2 million with Hexagon Capital Fund, extending subscription period. CEO and Director comment on the partnership

Biophytis Clinical Development Finance Hexagon Capital Fund Bond Facility
BRIEF

published on 01/28/2026 at 07:35, 3 months 11 days ago

Biophytis obtient un financement de 20 M$ pour sa Phase 3 en sarcopénie en Asie

Biophytis Asie Sarcopénie Phase 3 Joint-venture
BRIEF

published on 01/28/2026 at 07:35, 3 months 11 days ago

Biophytis Secures $20 Million for Sarcopenia Phase 3 Trial in Asia

Biophytis Joint Venture Phase 3 Trial Sarcopenia Asian Markets

Accesswire

Published on 05/09/2026 at 01:55, 1 hour ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 hour 15 minutes ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 hour 25 minutes ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 hours 55 minutes ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 3 hours 54 minutes ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/08/2026 at 20:38, 6 hours 17 minutes ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 7 hours 42 minutes ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 7 hours 53 minutes ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 8 hours 26 minutes ago

Designated Person Notification
Published on 05/08/2026 at 18:29, 8 hours 26 minutes ago

Designated Person Notification

Les Echos

Published on 05/07/2026 at 19:15, 1 day 7 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 7 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 7 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 7 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 7 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE